4-Methyl-2-propan-2-ylpyridin-3-amine is a pharmaceutial intermediate that typically in the preparation of AMG-510 as a potent KRAS G12C covalent inhibitor for the treatment of a number of disorders, including pancreatic, colorectal, and lung cancers.
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME. 
INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME. 
 B.A.Lanman, et al, US2018/334454 A1.
 B.A.Lanman, et al, US2019/77801 A1.
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email email@example.com.